Olema Pharmaceuticals Ownership | Who Owns Olema Pharmaceuticals?

Olema Pharmaceuticals Ownership Summary

Olema Pharmaceuticals is owned by 13.91% institutional investors, 3.28% insiders, and 82.82% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 8.00% of OLMA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.86% of its assets in Olema Pharmaceuticals shares.

OLMA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Olema Pharmaceuticals	13.91%	3.28%	82.82%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bain capital life sciences investors	6.84M	8.00%	$67.00M
Paradigm biocapital advisors lp	6.79M	7.95%	$66.51M
Blackrock	4.00M	7.11%	$43.27M
Bvf inc/il	5.30M	6.19%	$51.85M
Blackrock funding, inc. /de	4.73M	5.53%	$46.27M
Deep track capital, lp	3.47M	4.06%	$33.97M
Logos global management lp	3.21M	3.75%	$31.41M
Vanguard group	3.20M	3.74%	$31.30M
Franklin resources	3.01M	3.52%	$29.49M
Woodline partners lp	2.22M	2.59%	$21.71M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lightspeed management	1.93M	5.87%	$18.90M
Bain capital life sciences investors	6.84M	4.45%	$67.00M
Logos global management lp	3.21M	2.82%	$31.41M
Bvf inc/il	5.30M	2.10%	$51.85M
Paradigm biocapital advisors lp	6.79M	1.89%	$66.51M
Ghost tree capital	550.00K	1.86%	$5.95M
Birchview capital, lp	174.00K	1.29%	$1.70M
Silverarc capital management	933.54K	1.23%	$9.14M
Vivo capital	1.51M	1.19%	$14.74M
Highvista strategies	437.18K	1.05%	$4.28M

Top Buyers

Holder	Shares	% Assets	Change
Silverarc capital management	933.54K	1.23%	933.54K
Kingdon capital management	854.00K	1.04%	854.00K
Blackrock	4.00M	0.00%	782.96K
Boxer capital	650.00K	0.37%	650.00K
Soleus capital management	619.87K	0.31%	619.87K

Top Sellers

Holder	Shares	% Assets	Change
Bioimpact capital	-	-	-2.38M
Avoro capital advisors	-	-	-1.65M
Woodline partners lp	2.22M	0.10%	-1.29M
Polar capital	-	-	-1.00M
Great point partners	-	-	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
Silverarc capital management	933.54K	1.23%	933.54K	$9.14M
Kingdon capital management	854.00K	1.04%	854.00K	$8.36M
Boxer capital	650.00K	0.37%	650.00K	$7.03M
Soleus capital management	619.87K	0.31%	619.87K	$6.07M
Quantinno capital management lp	40.33K	0.00%	40.33K	$394.83K

Sold Out

Holder	Change
Swan capital	-1.00
Advisor group	-5.00
Nelson, van denburg & campbell wealth management group	-6.00
Abich financial wealth management	-10.00
Us bancorp \de\	-30.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	47	-58.77%	11,890,120	-82.11%	13	0.23%	20	-71.43%	15	-37.50%
Jun 30, 2025	119	-10.53%	70,425,751	6.89%	82	1.38%	73	5.80%	25	-43.18%
Mar 31, 2025	10	-93.71%	26,757,361	-62.46%	45	0.29%	5	-94.57%	4	-89.19%
Dec 31, 2024	158	17.04%	71,277,656	21.51%	124	1.19%	91	35.82%	38	-7.32%
Sep 30, 2024	135	4.65%	58,661,342	1.34%	102	0.97%	68	-16.05%	41	28.13%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.96M	2.86%	-43.21K
Vanguard US Total Market Shares ETF	1.49M	2.18%	-
iShares Russell 2000 ETF	1.45M	2.11%	-
Franklin Biotechnology Discv A(acc)USD	1.32M	1.93%	-
Candriam Global Equities Oncology	860.55K	1.50%	187.55K
Pictet-Biotech P USD	931.49K	1.36%	11.40K
Franklin Small Cap Growth SMA	917.80K	1.34%	917.80K
Franklin US Small Cap Growth Equity	917.80K	1.34%	24.60K
Franklin Small Cap Growth Adv	893.20K	1.30%	-
Belfius Equities Cure C Cap	850.45K	1.24%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 16, 2025	Harmon Cyrus	-	Sell	$15.47K
Sep 18, 2025	Harmon Cyrus	-	Sell	$25.68K
Sep 18, 2025	Harmon Cyrus	-	Sell	$83.30K
Sep 16, 2025	Harmon Cyrus	-	Sell	$80.40K
Jan 08, 2025	Bain Capital Life Sciences Investors, LLC	-	Buy	$1.73M

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	4
2025 Q2	-	-
2025 Q1	1	-
2024 Q4	2	17

OLMA Ownership FAQ

Who Owns Olema Pharmaceuticals?

Olema Pharmaceuticals shareholders are primarily institutional investors at 13.91%, followed by 3.28% insiders and 82.81% retail investors. The average institutional ownership in Olema Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Olema Pharmaceuticals falls below.

Who owns the most shares of Olema Pharmaceuticals?

Olema Pharmaceuticals’s largest shareholders are Bain capital life sciences investors (6.84M shares, 8.00%), Paradigm biocapital advisors lp (6.79M shares, 7.95%), and Blackrock (4M shares, 7.11%). Together, they hold 23.06% of Olema Pharmaceuticals’s total shares outstanding.

Does Blackrock own Olema Pharmaceuticals?

Yes, BlackRock owns 7.11% of Olema Pharmaceuticals, totaling 4M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 43.27M$. In the last quarter, BlackRock increased its holdings by 782.96K shares, a 24.34% change.

Who is Olema Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lightspeed management is Olema Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.87% of its assets in 1.93M Olema Pharmaceuticals shares, valued at 18.9M$.

Who is the top mutual fund holder of Olema Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Olema Pharmaceuticals shares, with 2.86% of its total shares outstanding invested in 1.96M Olema Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools